Bone marrow transplantation in 33 patients with malignant blood diseases and severe aplastic anaemia
暂无分享,去创建一个
J. Biggs | K. Atkinson | R. Penny | A. Dodds | A. Concannon | M. Nicholls | A. Ting | Jock Harkness | Philip Yuile | Peter Causer | Helen Bashir | Anthony Pun | Margot Honeyman | Jock L Harkness
[1] K. Atkinson,et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes , 1983, British journal of haematology.
[2] J. Biggs,et al. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation , 1983, British journal of haematology.
[3] D. Catovsky,et al. MARROW TRANSPLANTATION FOR PATIENTS IN THE CHRONIC PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.
[4] P. Neiman,et al. TREATMENT OF CHRONIC GRANULOCYTIC LEUKAEMIA IN CHRONIC PHASE BY ALLOGENEIC MARROW TRANSPLANTATION , 1982, The Lancet.
[5] D. Arthur,et al. SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS IN THE ACCELERATED PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.
[6] H. Deeg,et al. Cyclosporin-A abrogates transfusion-induced sensitization and prevents marrow graft rejection in DLA-identical canine littermates. , 1982, Blood.
[7] R. Storb,et al. Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. , 1982, International journal of radiation oncology, biology, physics.
[8] E. Gordon-Smith,et al. USE OF CYCLOSPORIN A IN ALLOGENEIC BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA , 1982, Transplantation.
[9] R. Powles,et al. BONE-MARROW TRANSPLANTATION IN LEUKAEMIA REMISSION , 1982, The Lancet.
[10] H. Ochs,et al. Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. , 1982, Transplantation.
[11] K. Sullivan,et al. Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. , 1982, Leukemia research.
[12] K. Sullivan,et al. Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation. , 1982, Leukemia research.
[13] Kristine,et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. , 1982, Blood.
[14] R. Storb,et al. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. , 1981, The New England journal of medicine.
[15] B. Speck,et al. EFFECT OF CYCLOSPORIN A ON IMMUNOLOGICAL RECOVERY AFTER BONE MARROW TRANSPLANTATION , 1981, The Lancet.
[16] K. Sullivan,et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.
[17] M. Homberger,et al. A radioimmunoassay to measure cyclosporin A in plasma and serum samples. , 1981, Journal of immunoassay.
[18] D. Rosenthal,et al. Treatment of acute myelogenous leukemia in children and adults. , 1980, The New England journal of medicine.
[19] D. Hedley,et al. THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA , 1980, The Lancet.
[20] J. Sloane,et al. CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION , 1980, The Lancet.
[21] P. Neiman,et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.
[22] A. Barrett,et al. CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN , 1978, The Lancet.
[23] J. Sprent,et al. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.
[24] R. Storb,et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. , 1974, Transplantation proceedings.
[25] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[26] J. Fennelly,et al. Intensive chemotherapy of acute myelogenous leukaemia. , 1972, Journal of the Irish Medical Association.
[27] R Storb,et al. Technique for human marrow grafting. , 1970, Blood.